Epidemiology of Age-related Hearing Loss

$733,364R37FY2016AGNIH

University Of Wisconsin-Madison, Madison WI

Investigators

Linked publications & trials

Paper 36412130 Paper 35526325 Paper 34924380 Paper 34185592 Paper 33211071 Paper 32693658 Paper 32011900 Paper 31385821 Paper 31282945 Paper 31135964 Paper 30698838 Paper 30572074 Paper 30461399 Paper 30318941 Paper 29757919 Paper 29710267 Paper 28770004 Paper 28584858 Paper 28139160 Paper 28000220 Paper 27941404 Paper 27611845 Paper 26946102 Paper 26140300 Paper 26082178 Paper 26079710 Paper 25953199 Paper 25760329 Paper 25123210 Paper 24899378 Paper 24888710 Paper 24828217 Paper 24560520 Paper 24518430 Paper 24481424 Paper 24135745 Paper 24023369 Paper 23889670 Paper 23814681 Paper 23758015 Paper 23739996 Paper 23632267 Paper 23399375 Paper 23063622 Paper 23001569 Paper 22854188 Paper 22588269 Paper 22232408 Paper 21933299 Paper 21871479 Paper 21866089 Paper 21680930 Paper 21439697 Paper 21298645 Paper 21195728 Paper 21194676 Paper 20848364 Paper 20730018 Paper 20564662 Paper 20560859 Paper 20008889 Paper 20006279 Paper 19995199 Paper 19853647 Paper 19743764 Paper 19686189 Paper 19686188 Paper 19633561 Paper 19474454 Paper 19266697 Paper 18843014 Paper 18795468 Paper 18662205 Paper 17851219 Paper 16044073 Paper 15955982 Paper 15844739 Paper 15476736 Paper 14609785 Paper 14570962 Paper 14568784 Paper 12489896 Paper 12425708 Paper 12141389 Paper 11589876 Paper 11296936 Paper 11037015 Paper 10980773

Abstract

Hearing, olfactory, and cognitive impairments are common health problems for aging adults. Age-related declines in sensory and cognitive function contribute to decreased quality of life in older adults. The purpose of this 21-yrfollow-study of a population-based cohort is to identify factors contributing to declines in sensory (hearing and olfaction) and cognitive function with aging. Specifically, the aims are to determine if biomarkers of neuroprotection are associated with the incidence of sensory (hearing and olfaction) and cognitive impairments; if these markers or markers of inflammation and atherosclerosis are associated with declines in auditory and cognitive function or olfaction thresholds; if shared risk factors (inflammatory, vascular and neural factors) contribute to the association between sensory disorders and risk of cognitive impairment; and to identify factors contributing to successful aging, measured by sensory and cognitive function. Subjects are participants in the population-based Epidemiology of Hearing Loss Study (EHLS) and were 48-92 years of age at the baseline examination (1993-95). The cohort was re-examined in 1998-2000, 2003-05, and 2009-2010. The proposed examination will use the same standardized protocols for hearing, olfaction, and cognitive testing, cardiovascular measures, and health questionnaires used in the last phase. New measures will include olfaction thresholds and questions about psychological traits. Laboratory analyses for a panel of biomarkers (cystatin-c, brain-derived neurotrophic factor, insulin-like growth factor-1, Cortisol, and aldosterone) will be conducted on stored samples from two time points. Analyses will use the repeated measures available from this longitudinal study to focus on the effects of long-term exposures. Results from this study will contribute to identifying new strategies to slow the declines in hearing, olfactory, and cognitive function with aging. Our multi-system approach will provide important information useful for planning interventions to promote successful sensory and cognitive aging.

View original record on NIH RePORTER →